Lancet

The most recent articles from: Lancet September 2017

Lancet · Sep 2017

Historical Article

Tuberculosis and HIV/AIDS: the alien and the predator.

no abstract available

read more… or not…
Lancet · Sep 2017

Historical Article

Russian medicine: trying to catch up on scientific evidence and human values.

no abstract available

read more… mark as read…
Lancet · Sep 2017

Historical Article

Public health in Russia: a sad state of affairs.

no abstract available

read more… or not…
Lancet · Sep 2017

Comment Letter

Tranexamic acid for post-partum haemorrhage in the WOMAN trial.

no abstract available

read on… or not…
Lancet · Sep 2017

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial.

Previous bisphosphonate treatment attenuates the bone-forming effect of teriparatide. We compared the effects of 12 months of romosozumab (AMG 785), a sclerostin monoclonal antibody, versus teriparatide on bone mineral density (BMD) in women with postmenopausal osteoporosis transitioning from bisphosphonate therapy. ⋯ Amgen, Astellas, and UCB Pharma.

explore further… or not…

1
2
3
4
5
6
7
8
9
…
24
25

Want more great medical articles?

Keep up to date with a free trial of metajournal, personalized for your practice.
1,694,794 articles already indexed!